Hydrochlorothiazide; metoprolol succinate - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for hydrochlorothiazide; metoprolol succinate and what is the scope of patent protection?
Hydrochlorothiazide; metoprolol succinate
is the generic ingredient in one branded drug marketed by Concordia and is included in one NDA. Additional information is available in the individual branded drug profile pages.Summary for hydrochlorothiazide; metoprolol succinate
| US Patents: | 0 |
| Tradenames: | 1 |
| Applicants: | 1 |
| NDAs: | 1 |
| Clinical Trials: | 1 |
| DailyMed Link: | hydrochlorothiazide; metoprolol succinate at DailyMed |
Recent Clinical Trials for hydrochlorothiazide; metoprolol succinate
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| AstraZeneca | Phase 3 |
See all hydrochlorothiazide; metoprolol succinate clinical trials
Anatomical Therapeutic Chemical (ATC) Classes for hydrochlorothiazide; metoprolol succinate
US Patents and Regulatory Information for hydrochlorothiazide; metoprolol succinate
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Concordia | DUTOPROL | hydrochlorothiazide; metoprolol succinate | TABLET, EXTENDED RELEASE;ORAL | 021956-002 | Aug 28, 2006 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Concordia | DUTOPROL | hydrochlorothiazide; metoprolol succinate | TABLET, EXTENDED RELEASE;ORAL | 021956-003 | Aug 28, 2006 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Concordia | DUTOPROL | hydrochlorothiazide; metoprolol succinate | TABLET, EXTENDED RELEASE;ORAL | 021956-001 | Aug 28, 2006 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
